Trade Raysearch Laboratories B - RAYb CFD
Add to favourite- Summary
- Historical Data
| Spread | 4.6 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.016348% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.005874% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | SEK | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Sweden | ||||||||
| Commission on trade | 0% |
| Prev. Close | 229.2 |
| Open | 229.7 |
| 1-Year Change | 157.22% |
| Day's Range | 226.2 - 233.7 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 16, 2025 | 229.2 | 1.0 | 0.44% | 228.2 | 232.7 | 228.2 |
| Jan 15, 2025 | 231.7 | 7.0 | 3.12% | 224.7 | 231.7 | 224.7 |
| Jan 14, 2025 | 229.7 | 1.5 | 0.66% | 228.2 | 235.2 | 228.2 |
| Jan 13, 2025 | 229.2 | -1.5 | -0.65% | 230.7 | 230.7 | 223.7 |
| Jan 10, 2025 | 230.7 | 4.5 | 1.99% | 226.2 | 231.7 | 223.7 |
| Jan 9, 2025 | 227.2 | 3.0 | 1.34% | 224.2 | 227.7 | 223.2 |
| Jan 8, 2025 | 223.7 | 4.0 | 1.82% | 219.7 | 225.7 | 219.2 |
| Jan 7, 2025 | 219.2 | 1.5 | 0.69% | 217.7 | 222.7 | 215.7 |
| Jan 3, 2025 | 219.2 | 1.0 | 0.46% | 218.2 | 222.2 | 214.2 |
| Jan 2, 2025 | 221.7 | 6.0 | 2.78% | 215.7 | 224.2 | 215.7 |
| Dec 30, 2024 | 213.2 | 1.5 | 0.71% | 211.7 | 215.2 | 207.2 |
| Dec 27, 2024 | 208.7 | 2.0 | 0.97% | 206.7 | 213.7 | 203.2 |
| Dec 23, 2024 | 207.2 | 4.5 | 2.22% | 202.7 | 209.2 | 196.8 |
| Dec 20, 2024 | 202.2 | 5.3 | 2.69% | 196.9 | 203.2 | 196.9 |
| Dec 19, 2024 | 203.7 | 5.4 | 2.72% | 198.3 | 205.2 | 197.5 |
| Dec 18, 2024 | 204.2 | 3.5 | 1.74% | 200.7 | 205.7 | 199.5 |
| Dec 17, 2024 | 200.7 | 1.6 | 0.80% | 199.1 | 202.7 | 198.1 |
| Dec 16, 2024 | 201.7 | -2.5 | -1.22% | 204.2 | 207.7 | 198.8 |
| Dec 13, 2024 | 207.2 | 6.0 | 2.98% | 201.2 | 209.2 | 201.2 |
| Dec 12, 2024 | 201.7 | 2.2 | 1.10% | 199.5 | 202.7 | 199.0 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Raysearch Company profile
About RaySearch Laboratories AB (publ)
RaySearch Laboratories publ AB is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, RaySearch Laboratories AB (publ) revenues decreased 2% to SEK641.1M. Net loss increased from SEK9.1M to SEK47.3M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Research and development expenditure - B increase from SEK41K to SEK62.4M (expense), Amortization in R&D increase of 22% to SEK166.7M (expense).
Equity composition
June 2003: Capital restructuring, name changed from Taurus Petroleum AB to RaySearch and FY end date changed from Aug to Dec. Reverse stock split in the ratio 20:1, par value increased to SEK1.50 and a new issue of 4,212,607 A-Shares and 5,877,633 B-Shares. 06/2008, 3-for-1 stock split.
| Industry: | Medical Software & Technology Services |
Eugeniavägen 18C
STOCKHOLM
STOCKHOLM 104 30
SE
News
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com